Abstract
For fifty years, dithiothreitol (DTT) has been the preferred reagent for the reduction of disulfide bonds in proteins and other biomolecules. Herein we report on the synthesis and characterization of 2,3-bis(mercaptomethyl)pyrazine (BMMP), a readily accessible disulfide-reducing agent with reactivity under biological conditions that is markedly superior to DTT and other known reagents.
The redox state of cysteine residues can have a profound effect on protein structure and function.1–4 Consequently, reagents that reduce disulfide bonds to thiols can be crucial to progress in chemical biology.1,5–6 Necessarily, the reduction of disulfide bonds within biomolecules must be accomplished under mild conditions: in water, at neutral pH, and at room temperature.7,1,8–10 Thiols can accomplish these goal and do so (unlike phosphines) in a reversible manner. Their reduction mechanism entails thiol–disulfide interchange initiated by the attack of a thiolate.11–18 The use of monothiols such as l-glutathione or βmercaptoethanol (βME) can lead to the trapping of the resulting intermediate as a mixed disulfide. In 1964, Cleland reported that dithiothreitol (DTT or Cleland’s reagent; Fig. 1), a racemic dithiol, readily completes the reduction reaction by forming a stable six-membered ring.7 The potency of DTT is evident from the low reduction potential (E°′ = −0.327 V) of its oxidized form.19 As a result, DTT has achieved widespread use for the quantitative reduction of disulfide bonds in proteins and other biomolecules.
Fig. 1.
Physicochemical properties of dithiol reducing agents. aValues are from ref.11.bValue is from ref. 19. cValues are from this work. dValues are from ref. 23.
DTT has, however, a serious limitation. As thiolates but not thiols are nucleophilic in aqueous solutison,20 the observed rate of disulfide reduction is dependent on the thiol pKa of the reducing agent. With thiol pKa values of 9.2 and 10.1, <1% of DTT resides in the reactive thiolate form at neutral pH.8 As a result, several attempts have been made to create water-soluble reducing agents that sport depressed thiol pKa values.21–22,9
Recently, we reported on dithiobutylamine (DTBA; Fig. 1), a dithiol reducing agent derived from l-aspartic acid.23 Like DTT, DTBA is a potent disulfide-reducing agent. Moreover, the amino group of DTBA confers depressed thiol pKa values of 8.2 and 9.3 and facile functionalization.23–24 That amino group, however, appeared to deter the ability of the molecule to reduce certain disulfide bonds due to unfavorable Coulombic interactions.23
We were determined to improve upon DTBA. Dithiols (like DTBA and DTT) that form six-membered cyclic disulfides are potent reducing agents, reflecting a balance between the high enthalpic stability of the incipient ring and the low entropic loss for its formation.25,19 We reasoned that the entropic loss could be diminished further by limiting rotation around one of the bonds between the two sulfhydryl groups. We also sought an electron-withdrawing group that could lower a thiol pKa to a value close to physiological pH (which is pH 7.365 in human blood). Then, an optimal balance is achieved between the concentration of the thiolate nucleophile (low pKa is better) and its incipient nucleophilicity (high pKa is better).26,11 Accordingly, we suspected that incorporating a highly electron-deficient moiety (e.g., a pyrazine ring) that also serves to preorganize the reagent for disulfide-bond formation could be advantageous. A compound that fits this description is 2,3-bis(mercaptomethyl)pyrazine (BMMP; Fig. 1).
Prior to designing a synthetic route to BMMP, we calculated the free energies for the optimized geometry of reduced BMMP and oxidized BMMP and compared them to those of reduced DTT and oxidized DTT. We were aware of a prior study that predicted the stability of cyclic disulfides using molecular mechanics calculations,25 and sought to assess our design at a higher level of theory (B3LYP/6-311+G(2d,p),27 see supporting information). The thiol pKa values of BMMP were calculated to be substantially lower than those of DTT. Moreover, the oxidation of BMMP was calculated to be slightly more favorable than that of DTT.
Because of these encouraging computational results, we synthesized BMMP from 2,3-dimethylpyrazine (1) via a simple three-step route (Scheme 1). We isolated BMMP as an off-white/yellow powder in 22% overall yield. The compound has low odor and aqueous solubility (64 mM reduced; 8 mM oxidized) that is adequate for typical applications in chemical biology.
Scheme 1.
Synthetic route to BMMP (4).
As predicted, BMMP has low thiol pKa values. A pH titration monitored by UV spectroscopy revealed these values to be 7.6 ± 0.1 and 9.0 ± 0.1. These pKa values are significantly lower than those of DTT and DTBA (Fig. 1).28,23 Moreover, the lower of its two thiol pKa values is closer to physiological pH than any known dithiol-based reducing agent (vide infra).8,21,29
BMMP was also found to be a potent reducing agent, albeit slightly less than predicted by our calculations. We found that the equilibrium reaction between reduced BMMP and oxidized DTT favors those species (rather than oxidized BMMP and reduced DTT) by ~1.2 kcal/mol, which corresponds to a reduction potential of E°′ = (−0.301 ± 0.003) V (Fig. 1 and S2) for oxidized BMMP. This E°′ value is slightly less negative than both DTT and DTBA, and presumably results from the decreased enthalpic stability imparted by the two sp2-hybridized carbons in its six-membered ring.25 BMMP is, however, a much more potent reducing agent than common monothiols such as βmercaptoethanol (βME), cysteamine, and l-glutathione.16,30 To probe this difference, we equilibrated oxidized βME (βMEox) with a slight excess of reduced BMMP for 24 h. Analysis by HPLC revealed the complete reduction of βMEox (Fig. S3).
Singh and Whitesides put forth N,N′-dimethyl-N,N′-bis(mercaptoacetyl)hydrazine (DMH; Fig. 1) as a faster disulfide-reducing agent than DTT.21 Notably, their reported pKa = 7.6 (8.9) and E°′ = –0.300 V values for DMH are indistinguishable from those of BMMP (Fig. 1). The E°′ value of DMH was corrected subsequently by Lees and Whitesides to be −0.272 V,19 which is more consistent with its forming an 8-membered ring upon oxidation. To our knowledge, the pKa value of DMH had not been examined again. Accordingly, we synthesized DMH so as to reexamine its properties and utility. Our observed value of E°′ = (−0.262 ± 0.003) V for DMH was even higher than that of Lees and Whitesides, and confirms that DMH is a markedly weaker reducing agent than is BMMP, DTBA, or DTT (Fig. 1). Likewise, our value of pKa = 8.0 ± 0.1 (Fig. 1) is higher than that reported by Singh and Whitesides, but consistent with values reported for mercaptoacetamido groups.22,9,31
Next, we analyzed the reactivity of BMMP with relevant disulfide bonds. At pH 7.0, BMMP reduced the disulfide bond in βMEox 11-fold faster than did DTT and 3-fold faster than did DTBA (Fig. 2A; Table 1S). Commensurate with their pKa values, DMH reduced βMEox faster than did DTT or DTBA but slower than did BMMP. At pH 5.0, BMMP reduced βMEox 14-fold faster than DTT and 4-fold faster than did DTBA (Fig. 2B; Table 1S). These data highlight the broad pH-range at which BMMP can be utilized effectively.
Fig. 2.
Time-course for the reduction of βMEox (5mM) by BMMP, DMH, DTBA, or DTT (5mM) in buffered water. (A) In 50 mM potassiumphosphate buffer, pH 7.0: . (B) In 50 mM sodium acetate buffer, pH 5.0: .
Finally, we assessed the ability of BMMP to reduce disulfide bonds in two proteins. Papain is a cysteine protease that contains an active-site sulfhydryl group (Cys25) that needs to be in a reduced state for catalysis.32 Treatment with S-methyl methanethiosulfonate generates an active-site mixed disulfide that results in complete loss of enzymatic activity.33 This loss in activity, however, is reversible upon treatment with a disulfide-reducing agent. We found that BMMP reduced the mixed disulfide in papain 13-fold faster than did DTT and at a rate comparable to that of DTBA (Fig. 3A; Table 1S).23
Fig. 3.
Time-course for the reduction of a mixed disulfide in proteins by BMMP, DTBA, or DTT (7.8 µM) in 0.10 M imidazole–HCl buffer, pH 7.0, containing EDTA (2 mM). (A) Papain Cys25–S–S–CH3 (4.4 µM): . (B) Creatine kinase Cys283–S–S–l-glutathione(0.34 µM): .
Creatine kinase, like papain, is an enzyme that contains a thiol group (Cys283) that needs to be in a reduced state for catalytic function.34–37 When treated with oxidized l-glutathione, the resulting mixed disulfide eliminates its enzymatic activity. Previously, we reported that the ability of DTBA to reduce this disulfide bond was compromised—presumably by unfavorable Coulombic interactions—resulting in a low reaction rate comparable to that of DTT.23 In contrast to DTBA, BMMP is not cationic near neutral pH. (For example, the pKa of the conjugate acid of 2,5-dimethylpyrazine is 2.1.38) Indeed, unfavorable Coulombic interactions were not apparent with BMMP, which was found to reduce the mixed disulfide in creatine kinase 6-fold faster than did DTT and 7-fold faster than did DTBA (Fig. 3B; Table 1S).
In conclusion, we have designed, synthesized, and characterized BMMP, a novel disulfide-reducing agent with high reactivity under biological conditions. The pyrazine ring of BMMP fuels its enhanced performance without Coulombic consequences. In a variety of relevant assays, BMMP reduces disulfide bonds ~10-fold faster than does DTT. Notably, the depressed thiol pKa values of BMMP extended the pH range at which disulfide bonds can be reduced efficiently. These attributes render BMMP as an attractive reagent for the reduction of the disulfide bonds encountered in chemical biology.
Supplementary Material
Acknowledgments
We are grateful to Robert W. Newberry for advice on computations. This work was supported by grant R01 GM044783 (NIH), and made use of the National Magnetic Resonance Facility at Madison, which is supported by grant P41 GM103399 (NIH).
Footnotes
Electronic Supplementary Information (ESI) available: Experimental procedures, computational data, and spectral data for novel compounds.
Notes and References
- 1.Jocelyn PC, editor. Biochemistry of the SH Group: The Occurence, Chemical Properties, Metabolism and Biological Function of Thiols and Disulfides. London, U.K.: 1972. [Google Scholar]
- 2.Jacob C, Giles GI, Giles NM, Sies H. Angew. Chem. Int. Ed. 2003;42:4742–4758. doi: 10.1002/anie.200300573. [DOI] [PubMed] [Google Scholar]
- 3.Buchner J, Moroder L, editors. Oxidative Folding of Peptides and Proteins, The Royal Society of Chemistry. Cambridge, UK: 2009. [Google Scholar]
- 4.Lindahl M, Mata-Cabana A, Kieselbach T. Antioxid. Redox Signal. 2011;14:2581–2642. doi: 10.1089/ars.2010.3551. [DOI] [PubMed] [Google Scholar]
- 5.Gilbert HF. Adv. Enzymol. 1990;63:69–172. doi: 10.1002/9780470123096.ch2. [DOI] [PubMed] [Google Scholar]
- 6.Kim PS, Baldwin RL. Annu. Rev. Biochem. 1990;59:631–660. doi: 10.1146/annurev.bi.59.070190.003215. [DOI] [PubMed] [Google Scholar]
- 7.Cleland WW. Biochemistry. 1964;3:480–482. doi: 10.1021/bi00892a002. [DOI] [PubMed] [Google Scholar]
- 8.Szajewski RP, Whitesides GM. J. Am. Chem. Soc. 1980;102:2011–2026. [Google Scholar]
- 9.Lamoureux GV, Whitesides GM. J. Org. Chem. 1993;58:633–641. [Google Scholar]
- 10.Van Laer K, Hamilton CJ. J. Messens. Antioxid. Redox Signal. 2013;18:1642–1653. doi: 10.1089/ars.2012.4964. [DOI] [PubMed] [Google Scholar]
- 11.Whitesides GM, Lilburn JE, Szajewski RP. J. Org. Chem. 1977;42:332–338. [Google Scholar]
- 12.Snyder JP, Carlsen L. J. Am. Chem. Soc. 1977;99:2931–2942. [Google Scholar]
- 13.Rosenfield RE, Parthasarathy R, Dunitz JD. J. Am. Chem. Soc. 1977;99:4860–4862. [Google Scholar]
- 14.Shaked Z, Szajewski RP, Whitesides GM. Biochemistry. 1980;19:4156–4166. doi: 10.1021/bi00559a004. [DOI] [PubMed] [Google Scholar]
- 15.Houk J, Whitesides GM. J. Am. Chem. Soc. 1987;109:6825–6836. [Google Scholar]
- 16.Keire DA, Strauss E, Guo W, Noszal B, Rabenstein DL. J. Org. Chem. 1992;57:123–127. [Google Scholar]
- 17.Rothwarf DM, Scheraga HA. Proc. Natl. Acad. Sci. U.S.A. 1992;89:7944–7948. doi: 10.1073/pnas.89.17.7944. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Fernandes PA, Ramos MJ. Chem. Eur. J. 2004;10:257–266. doi: 10.1002/chem.200305343. [DOI] [PubMed] [Google Scholar]
- 19.Lees WJ, Whitesides GH. J. Org. Chem. 1993;58:642–647. [Google Scholar]
- 20.Bednar RA. Biochemistry. 1990;29:3684–3690. doi: 10.1021/bi00467a014. [DOI] [PubMed] [Google Scholar]
- 21.Singh R, Whitesides GM. J. Org. Chem. 1991;56:2332–2337. [Google Scholar]
- 22.Lees WJ, Singh R, Whitesides GM. J. Org. Chem. 1991;56:7328–7331. [Google Scholar]
- 23.Lukesh JC, III, Palte MJ, Raines RT. J. Am. Chem. Soc. 2012;134:4057–4059. doi: 10.1021/ja211931f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lukesh JC, III, VanVeller B, Raines RT. Angew. Chem. Int. Ed. 2013;52:12901–12904. doi: 10.1002/anie.201307481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Burns JA, Whitesides GM. J. Am. Chem. Soc. 1990;112:6296–6303. [Google Scholar]
- 26.Jencks WP. Catalysis in Chemistry and Enzymology. New York, NY: McrGraw–Hill; 1969. pp. 79–85. [Google Scholar]
- 27.Frisch MJT, Schlegel GW, Scuseria HB, Robb GE, Cheeseman MA, Scalmani JR, Barone G, Mennucci V, Petersson B, Nakatsuji GA, Caricato H, Li M, Hratchian X, Izmaylov HP, Bloino AF, Zheng J, Sonnenberg G, Hada JL, Ehara M, Toyota M, Fukuda K, Hasegawa R, Ishida J, Nakajima M, Honda T, Kitao Y, Nakai O, Vreven H, Montgomery T, Jr, Peralta JA, Ogliaro JE, Bearpark F, Heyd M, Brothers JJ, Kudin E, Staroverov KN, Kobayashi VN, Normand R, Raghavachari J, Rendell K, Burant A, Iyengar JC, Tomasi SS, Cossi J, Rega M, Millam N, Klene JM, Knox M, Cross JE, Bakken JB, Adamo V, Jaramillo C, Gomperts J, Stratmann R, Yazyev RE, Austin O, Cammi AJ, Pomelli R, Ochterski C, Martin JW, Morokuma RL, Zakrzewski K, Voth VG, Salvador GA, Salvador P, Dapprich JJ, Daniels S, Farkas AD, Foresman Ö, Ortiz JB, Cioslowski JV, Fox J, Gaussian DJ. Inc., Wallingford, CT; 2009. [Google Scholar]
- 28.Benesch RE, Benesch RJ. J. Am. Chem. Soc. 1955;77:5877–5881. [Google Scholar]
- 29.Patel AS, Lees WJ. Bioorg. Med. Chem. 2012;20:1020–1028. doi: 10.1016/j.bmc.2011.11.049. [DOI] [PubMed] [Google Scholar]
- 30.Millis KK, Weaver KH, Rabenstein DL. J. Org. Chem. 1993;58:4144–4146. [Google Scholar]
- 31.Woycechowsky KJ, Wittrup KD, Raines RT. Chem. Biol. 1999;6:871–879. doi: 10.1016/s1074-5521(00)80006-x. [DOI] [PubMed] [Google Scholar]
- 32.Schechter I, Berger A. Biochem. Biophys. Res. Commun. 1967;27:157–162. doi: 10.1016/s0006-291x(67)80055-x. [DOI] [PubMed] [Google Scholar]
- 33.Smith DJ, Maggio ET, Kenyon GL. Biochemistry. 1975;14:766–771. doi: 10.1021/bi00675a019. [DOI] [PubMed] [Google Scholar]
- 34.Putney S, Herlihy W, Royal N, Pang H, Aposhian HV, Pickering L, Belagaje R, Biemann K, Page D, Kuby S, Schimmel P. J. Biol. Chem. 1984;259:4317–4320. [PubMed] [Google Scholar]
- 35.Chen LH, Borders CL, Vasquez JR, Kenyon GL. Biochemistry. 1996;35:7895–7902. doi: 10.1021/bi952798i. [DOI] [PubMed] [Google Scholar]
- 36.Rao JKM, Bujacz G, Wlodawer A. FEBS Lett. 1998;439:133–137. doi: 10.1016/s0014-5793(98)01355-6. [DOI] [PubMed] [Google Scholar]
- 37.Hurne AM, Chai CLL, Waring P. J. Biol. Chem. 2000;275:25202–25206. doi: 10.1074/jbc.M002278200. [DOI] [PubMed] [Google Scholar]
- 38.Keyworth DA. J. Org. Chem. 1959;24:1355. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




